Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ho: Ibalizumab for HIV Prevention |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2011-11-21 |
| Study Made Public: | 2015-08-18 |
Title
Assessment of neutralization activity of antibody fragments against HIV entry
Description
CAVD 275 is an immunogenicity study to assess the neutralization activity of antibody fragments (Fab fragments) and peptides against HIV.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.